|
| INTRO EQUATIONS CRITERIA DECISION CONVERT SPECIALTIES REFS SEARCH NEW FHIR APP POLICIES CONTACT |
| CNS-IPI (International Prognostic Index for 2-year risk of CNS relapse in DLBCL treated with R-CHOP) in adults |
The EBMcalc module CNS-IPI (International Prognostic Index for 2-year risk of CNS relapse in DLBCL treated with R-CHOP) in adults is available in EBMcalc Complete Edition.
This calculator evaluates the following Clinical Criteria:
- Kidney and/or adrenal glands involved by lymphoma
- Age >60 years
- LDH >normal
- ECOG performance status (PS) >1*
- Stage III/IV disease
- Extranodal involvement >1
References
- Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982; 5:649. PubMed ID: 7165009
- Schmitz N, Zeynalova S, Nickelsen M, et al. CNS International Prognostic Index: A risk model for CNS relapse in patients with diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol. 2016; 34:3150. PubMed ID: 27382100
Legal Notices and Disclaimer All information contained in and produced by the EBMcalc system is provided for educational purposes only. This information should not be used for the diagnosis or treatment of any health problem or disease. THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER. EBMcalc is NOT a medical device. EBMcalc NEVER stores cookies or other persistent data in user's browsers. Click here for full notice and disclaimer. EBMcalc is Copyright © 1998-2026 EBMcalc, LLC [Build 279874 v26.1] |